Dr. David McClure has focused most of his professional efforts for the past 20 years on developing health-related products regulated by the US Food and Drug Administration (FDA) and cognate foreign regulatory agencies and bringing those products to market. David has led product development, manufacturing, regulatory and business development efforts for firms creating and/or manufacturing drugs, medical devices, medical foods, and cosmetic products. David has also consulted for publicly traded metals and health benefits companies on intellectual property value creation, served as chief patent counsel for a pharmaceutical company, director of regulatory affairs for a pharmaceutical and medical device company, and general counsel for human and veterinary healthcare products companies. David is a registered patent attorney, admitted in 1998 to practice before the US Patent and Trademark Office in patent matters. David also holds the RAC certificate from the Regulatory Affairs Certification Board and regularly represents companies before FDA in matters related to market access and regulatory compliance. David has served as adjunct professor of pharmacy law and ethics, as an Institutional Review Board member, and as a visiting professor of forensic chemistry. He has co-founded companies that have successfully out-licensed therapeutics and diagnostics for neurologic, infectious disease, cardiovascular, endocrine and oncology indications. While a graduate student, David was a Robert A. Welch Foundation fellow. He is a member of the Food and Drug Law Institute, Licensing Executives Society, and Association of University Technology Managers.
David McClure
Senior Consultant, M.S. Anatomical Sciences and Neurobiology, Ph.D. Biochemistry, J.D. Law, RAC